203 related articles for article (PubMed ID: 14696222)
1. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study.
Jacobs MA; Barker PB; Bottomley PA; Bhujwalla Z; Bluemke DA
J Magn Reson Imaging; 2004 Jan; 19(1):68-75. PubMed ID: 14696222
[TBL] [Abstract][Full Text] [Related]
2. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization.
Fayad LM; Bluemke DA; McCarthy EF; Weber KL; Barker PB; Jacobs MA
J Magn Reson Imaging; 2006 Jan; 23(1):23-8. PubMed ID: 16315208
[TBL] [Abstract][Full Text] [Related]
3. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
[TBL] [Abstract][Full Text] [Related]
5. Human breast lesions: characterization with proton MR spectroscopy.
Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
[TBL] [Abstract][Full Text] [Related]
6. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
Su MY; Baik HM; Yu HJ; Chen JH; Mehta RS; Nalcioglu O
Technol Cancer Res Treat; 2006 Aug; 5(4):401-10. PubMed ID: 16866570
[TBL] [Abstract][Full Text] [Related]
7. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.
Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033
[TBL] [Abstract][Full Text] [Related]
8. A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3 T.
Hu J; Feng W; Hua J; Jiang Q; Xuan Y; Li T; Haacke EM
Med Phys; 2009 Nov; 36(11):4870-7. PubMed ID: 19994494
[TBL] [Abstract][Full Text] [Related]
9. An improved 1H magnetic resonance spectroscopic imaging technique for the human breast: preliminary results.
Hu J; Vartanian SA; Xuan Y; Latif Z; Soulen RL
Magn Reson Imaging; 2005 May; 23(4):571-6. PubMed ID: 15919603
[TBL] [Abstract][Full Text] [Related]
10. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
11. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
[TBL] [Abstract][Full Text] [Related]
12. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
14. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
[TBL] [Abstract][Full Text] [Related]
15. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
Faeghi F; Baniasadipour B; Jalalshokouhi J
Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
[TBL] [Abstract][Full Text] [Related]
16. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
[TBL] [Abstract][Full Text] [Related]
17. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
18. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
19. Detection of choline signal in human breast lesions with chemical-shift imaging.
Baek HM; Chen JH; Yu HJ; Mehta R; Nalcioglu O; Su MY
J Magn Reson Imaging; 2008 May; 27(5):1114-21. PubMed ID: 18425841
[TBL] [Abstract][Full Text] [Related]
20. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]